The present invention provides compositions and uses thereof fortreating cancers which have acquired resistance to a KIT inhibitor byadministeringeffective amounts of DAST 4{4-[3-(4-chloro-3-trifluoromethylphenyl)-ureido]-3-fluorophenoxy}-pyridine-2-carboxylicacid methylamide of the formula I(see formula I).